Median | ||
---|---|---|
(range) | ||
PSA | 15.9 (2.8-260.0) | |
N (%) | ||
Clinical T-stage | 1 | 31 (22%) |
2 | 85 (62%) | |
3 | 22 (16%) | |
Gleason score | Unknown | 1 (1%) |
5 | 4 (3%) | |
6 | 32 (23%) | |
7 | 62 (45%) | |
8 | 26 (19%) | |
9 | 10 (7%) | |
10 | 3 (2%) | |
MRL Result | Negative | 114 (83%) |
Positive | 24 (17%) | |
Result PA | Negative | 122 (88%) |
Positive | 16 (12%) | |
Therapy | Prostatectomy | 77 (56%) |
Radiotherapy with neo-adjuvant hormonal treatment | 47 (34%) | |
Hormonal therapy | 14 (10%) |